BEAM THERAPEUTICS INC shareholders Q3 2023

BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 196 filers reported holding BEAM THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.13 and the average weighting 0.3%.

BEAM THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
MWG Management Ltd. 2,346,934$56,443,76354.70%
HSG Holding Ltd 796,089$19,145,9402.05%
Redmile Group, LLC 1,469,725$35,346,8861.68%
ARK Investment Management 8,783,891$211,252,5901.62%
Casdin Capital, LLC 570,000$13,708,5001.52%
Deep Track Capital, LP 1,015,641$24,426,1660.94%
Yiheng Capital Management, L.P. 560,500$13,480,0250.69%
Temasek Holdings (Private) Ltd 4,317,789$103,842,8250.62%
FARALLON CAPITAL MANAGEMENT LLC 4,481,839$107,788,2280.54%
Alphabet Inc. 321,604$7,734,5760.50%
Nikko Asset Management Americas, Inc. 1,642,180$39,461,5850.47%
Green Alpha Advisors, LLC 15,574$374,5550.29%
Bellevue Group AG 694,821$16,710,4450.27%
Corton Capital Inc. 20,505$493,1450.25%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 23,500$564,7050.19%
Contrarius Investment Management Ltd 126,968$3,0540.17%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 4,829$116,1370.16%
HARBOR CAPITAL ADVISORS, INC. 30,913$743,4580.16%
Clarius Group, LLC 60,615$1,457,7910.14%
Woodline Partners LP 449,732$10,816,0550.13%
External links

This page lists BEAM THERAPEUTICS INC's shareholders in Q3 2023. To view BEAM THERAPEUTICS INC's shareholder history, click here.